dactinomycin and Myositis

dactinomycin has been researched along with Myositis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lurati, M; Mertens, HG	1
Peters, JM; Reimer, G; Scheer, U; Tan, EM	1

Other Studies

2 other study(ies) available for dactinomycin and Myositis

Article	Year
[Immunosuppressive treatment of polymyositis]. Deutsche medizinische Wochenschrift (1946), 1975, Jan-10, Volume: 100, Issue:2 Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Dactinomycin; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Myositis; Prednisolone; Time Factors	1975
Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. Journal of immunology (Baltimore, Md. : 1950), 1986, Dec-15, Volume: 137, Issue:12 Topics: Animals; Antigens, Nuclear; Autoantibodies; Autoantigens; Cell Cycle; Cell Nucleolus; Dactinomycin; Dichlororibofuranosylbenzimidazole; Fluorescent Antibody Technique; HeLa Cells; Humans; Myositis; Nucleoproteins; Scleroderma, Systemic; Vero Cells	1986

Article

Year

[Immunosuppressive treatment of polymyositis].

Deutsche medizinische Wochenschrift (1946), 1975, Jan-10, Volume: 100, Issue:2

Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Dactinomycin; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Myositis; Prednisolone; Time Factors

1975

Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.

Journal of immunology (Baltimore, Md. : 1950), 1986, Dec-15, Volume: 137, Issue:12

Topics: Animals; Antigens, Nuclear; Autoantibodies; Autoantigens; Cell Cycle; Cell Nucleolus; Dactinomycin; Dichlororibofuranosylbenzimidazole; Fluorescent Antibody Technique; HeLa Cells; Humans; Myositis; Nucleoproteins; Scleroderma, Systemic; Vero Cells

1986